HAE

HAE Operating Cash Flow (Statement)

$328.15MTTM · USD

Period ending:

HAE FY Cash from OperationsUSD
HAE FY Cash from Operations1992-03-31: $18.80M1993-03-31: $35.90M1994-03-31: $27.00M1995-03-31: $15.60M1996-03-31: $54.80M1997-03-31: $26.70M1998-03-31: $20.40M1999-03-31: $33.70M2000-03-31: $53.47M2001-03-31: $61.01M2002-03-31: $32.24M2003-03-31: $43.67M2004-03-31: $74.61M2005-03-31: $71.21M2006-03-31: $85.62M2007-03-31: $83.56M2008-03-31: $77.67M2009-03-31: $116.36M2010-03-31: $130.67M2011-03-31: $123.46M2012-03-31: $115.32M2013-03-31: $85.07M2014-03-31: $139.52M2015-03-31: $127.18M2016-03-31: $121.87M2017-03-31: $159.74M2018-03-31: $220.35M2019-03-31: $159.28M2020-03-31: $158.22M2021-03-31: $108.81M2022-03-31: $172.26M2023-03-31: $273.06M2024-03-31: $181.75M2025-03-29: $181.73M2026-03-28: $293.22M$293.22M$0.00
1992-03-312026-03-28

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HAE operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 35 observations from Mar 31, 1992 to Mar 28, 2026.

Haemonetics Corp Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
293,221,000
181,725,000
181,751,000
273,058,000
172,263,000
108,805,000
158,217,000
159,281,000
220,350,000
159,738,000
121,865,000
127,178,000
139,524,000
85,074,000
115,318,000
123,455,000
130,668,000
116,364,000
77,669,000
83,563,000
85,616,000
71,207,000
74,610,000
43,667,000
32,238,000
61,010,000
53,465,000
33,700,000
20,400,000
26,700,000
54,800,000
15,600,000
27,000,000
35,900,000
18,800,000

Compare operating cash flow (statement)

All HAE financial metrics · HAE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.